Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy
CompletedOBSERVATIONAL
Enrollment
179
Participants
Timeline
Start Date
January 1, 2019
Primary Completion Date
December 31, 2022
Study Completion Date
September 1, 2025
Conditions
Gastric Cancer (GC)
Trial Locations (1)
350001
Fujian Medical University, Fuzhou
All Listed Sponsors
lead
Chang-Ming Huang, Prof.
OTHER
NCT07190040 - Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy | Biotech Hunter | Biotech Hunter